Literature DB >> 28533518

Blocking CRMP2 SUMOylation reverses neuropathic pain.

A Moutal1, E T Dustrude1, T M Largent-Milnes1, T W Vanderah1,2, M Khanna1, R Khanna3,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 28533518      PMCID： PMC5700854          DOI： 10.1038/mp.2017.117

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  25 in total

1.  CRMP5 (collapsin response mediator protein 5) regulates dendritic development and synaptic plasticity in the cerebellar Purkinje cells.

Authors:  Naoya Yamashita; Bedrich Mosinger; Arpita Roy; Mari Miyazaki; Kozue Ugajin; Fumio Nakamura; Yukio Sasaki; Kazuhiko Yamaguchi; Pappachan Kolattukudy; Yoshio Goshima
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

2.  Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex.

Authors:  Joel M Brittain; Djane B Duarte; Sarah M Wilson; Weiguo Zhu; Carrie Ballard; Philip L Johnson; Naikui Liu; Wenhui Xiong; Matthew S Ripsch; Yuying Wang; Jill C Fehrenbacher; Stephanie D Fitz; May Khanna; Chul-Kyu Park; Brian S Schmutzler; Bo Myung Cheon; Michael R Due; Tatiana Brustovetsky; Nicole M Ashpole; Andy Hudmon; Samy O Meroueh; Cynthia M Hingtgen; Nickolay Brustovetsky; Ru-Rong Ji; Joyce H Hurley; Xiaoming Jin; Anantha Shekhar; Xiao-Ming Xu; Gerry S Oxford; Michael R Vasko; Fletcher A White; Rajesh Khanna
Journal:  Nat Med       Date:  2011-06-05       Impact factor: 53.440

3.  Mouse pups lacking collapsin response mediator protein 4 manifest impaired olfactory function and hyperactivity in the olfactory bulb.

Authors:  Atsuhiro Tsutiya; Masugi Nishihara; Yoshio Goshima; Ritsuko Ohtani-Kaneko
Journal:  Eur J Neurosci       Date:  2015-07-23       Impact factor: 3.386

4.  Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.

Authors:  Steven Petratos; Ezgi Ozturk; Michael F Azari; Rachel Kenny; Jae Young Lee; Kylie A Magee; Alan R Harvey; Courtney McDonald; Kasra Taghian; Leon Moussa; Pei Mun Aui; Christopher Siatskas; Sara Litwak; Michael G Fehlings; Stephen M Strittmatter; Claude C A Bernard
Journal:  Brain       Date:  2012-04-28       Impact factor: 13.501

5.  Dysregulation of voltage-gated sodium channels by ubiquitin ligase NEDD4-2 in neuropathic pain.

Authors:  Cédric J Laedermann; Matthieu Cachemaille; Guylène Kirschmann; Marie Pertin; Romain-Daniel Gosselin; Isabelle Chang; Maxime Albesa; Chris Towne; Bernard L Schneider; Stephan Kellenberger; Hugues Abriel; Isabelle Decosterd
Journal:  J Clin Invest       Date:  2013-06-17       Impact factor: 14.808

6.  Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits.

Authors:  Verian Bader; Liisa Tomppo; Svenja V Trossbach; Nicholas J Bradshaw; Ingrid Prikulis; S Rutger Leliveld; Chi-Ying Lin; Koko Ishizuka; Akira Sawa; Adriana Ramos; Isaac Rosa; Ángel García; Jesús R Requena; Maria Hipolito; Narayan Rai; Evaristus Nwulia; Uwe Henning; Stefano Ferrea; Christian Luckhaus; Jesper Ekelund; Juha Veijola; Marjo-Riitta Järvelin; William Hennah; Carsten Korth
Journal:  Hum Mol Genet       Date:  2012-07-13       Impact factor: 6.150

7.  Autism-specific maternal autoantibodies recognize critical proteins in developing brain.

Authors:  D Braunschweig; P Krakowiak; P Duncanson; R Boyce; R L Hansen; P Ashwood; I Hertz-Picciotto; I N Pessah; J Van de Water
Journal:  Transl Psychiatry       Date:  2013-07-09       Impact factor: 6.222

8.  Sustained relief of neuropathic pain by AAV-targeted expression of CBD3 peptide in rat dorsal root ganglion.

Authors:  G Fischer; B Pan; D Vilceanu; Q H Hogan; H Yu
Journal:  Gene Ther       Date:  2013-10-24       Impact factor: 5.250

9.  mTORC1-dependent translation of collapsin response mediator protein-2 drives neuroadaptations underlying excessive alcohol-drinking behaviors.

Authors:  F Liu; S Laguesse; R Legastelois; N Morisot; S Ben Hamida; D Ron
Journal:  Mol Psychiatry       Date:  2016-03-08       Impact factor: 15.992

10.  Association of rare missense variants in the second intracellular loop of NaV1.7 sodium channels with familial autism.

Authors:  M Rubinstein; A Patowary; I B Stanaway; E McCord; R R Nesbitt; M Archer; T Scheuer; D Nickerson; W H Raskind; E M Wijsman; R Bernier; W A Catterall; Z Brkanac
Journal:  Mol Psychiatry       Date:  2016-12-13       Impact factor: 15.992
View more
  26 in total

1.  CRMP2-Neurofibromin Interface Drives NF1-related Pain.

Authors:  Aubin Moutal; Li Sun; Xiaofang Yang; Wennan Li; Song Cai; Shizhen Luo; Rajesh Khanna
Journal:  Neuroscience       Date:  2018-04-12       Impact factor: 3.590

2.  Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission.

Authors:  Jie Yu; Aubin Moutal; Angie Dorame; Shreya S Bellampalli; Aude Chefdeville; Iori Kanazawa; Nancy Y N Pham; Ki Duk Park; Jill M Weimer; Rajesh Khanna
Journal:  Mol Neurobiol       Date:  2018-12-18       Impact factor: 5.590

3.  Dynamic CRMP2 Regulation of CaV2.2 in the Prefrontal Cortex Contributes to the Reinstatement of Cocaine Seeking.

Authors:  William C Buchta; Aubin Moutal; Bethany Hines; Constanza Garcia-Keller; Alexander C W Smith; Peter Kalivas; Rajesh Khanna; Arthur C Riegel
Journal:  Mol Neurobiol       Date:  2019-07-29       Impact factor: 5.590

Review 4.  Mining the Nav1.7 interactome: Opportunities for chronic pain therapeutics.

Authors:  Lindsey A Chew; Shreya S Bellampalli; Erik T Dustrude; Rajesh Khanna
Journal:  Biochem Pharmacol       Date:  2019-01-27       Impact factor: 5.858

5.  DNMT3b SUMOylation Mediated MMP-2 Upregulation Contribute to Paclitaxel Induced Neuropathic Pain.

Authors:  Han Wang; Yi-Jia Shen; Xiu-Juan Li; Jun Xia; Li Sun; Yehao Xu; Yu Ma; Dai Li; Yuan-Chang Xiong
Journal:  Neurochem Res       Date:  2021-02-06       Impact factor: 3.996

Review 6.  Towards a neurobiological understanding of pain in neurofibromatosis type 1: mechanisms and implications for treatment.

Authors:  Shreya S Bellampalli; Rajesh Khanna
Journal:  Pain       Date:  2019-05       Impact factor: 6.961

7.  Downregulation of hippocampal SIRT6 activates AKT/CRMP2 signaling and ameliorates chronic stress-induced depression-like behavior in mice.

Authors:  Wang Li; Xin Liu; Hui Qiao
Journal:  Acta Pharmacol Sin       Date:  2020-04-07       Impact factor: 6.150

8.  A light-gated potassium channel for sustained neuronal inhibition.

Authors:  Laura Alberio; Andrea Locarno; Andrea Saponaro; Edoardo Romano; Valérie Bercier; Shahad Albadri; Federica Simeoni; Silvia Moleri; Silvia Pelucchi; Alessandro Porro; Elena Marcello; Noemi Barsotti; Kerri Kukovetz; Arjen J Boender; Andrea Contestabile; Shizhen Luo; Aubin Moutal; Yingshi Ji; Giulia Romani; Monica Beltrame; Filippo Del Bene; Monica Di Luca; Rajesh Khanna; Henry M Colecraft; Massimo Pasqualetti; Gerhard Thiel; Raffaella Tonini; Anna Moroni
Journal:  Nat Methods       Date:  2018-10-30       Impact factor: 28.547

9.  CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide.

Authors:  Aubin Moutal; Xiaofang Yang; Wennan Li; Kerry B Gilbraith; Shizhen Luo; Song Cai; Liberty François-Moutal; Lindsey A Chew; Seul Ki Yeon; Shreya S Bellampalli; Chaoling Qu; Jennifer Y Xie; Mohab M Ibrahim; May Khanna; Ki Duk Park; Frank Porreca; Rajesh Khanna
Journal:  Pain       Date:  2017-12       Impact factor: 7.926

Review 10.  SUMOylation of synaptic and synapse-associated proteins: An update.

Authors:  Jeremy M Henley; Richard Seager; Yasuko Nakamura; Karolina Talandyte; Jithin Nair; Kevin A Wilkinson
Journal:  J Neurochem       Date:  2020-07-05       Impact factor: 5.372
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.